论文部分内容阅读
羟羧氧酰胺菌素(Moxalactam)是一种新的供静脉注射的β-内酰胺抗生素,本文报道它作为单独的抗微生物感染药治疗多种菌感染疾病的临床效果.
Moxalactam, a new beta-lactam antibiotic for intravenous injection, is reported herein for its clinical utility as a single anti-microbial infective for the treatment of a variety of bacterial infections.